BlackRock
SBIO icon

BlackRock’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

BlackRock’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-371
Closed -$16K – 5151
2020
Q2 		$16K Buy
+371
New +$14.6K ﹤0.01% 4727

Other funds holding SBIO

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CCP
Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BlackRock's SBIO Position: Q3 2020 in Review

BlackRock sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q3 2020, closing a stake of 371 shares — an estimated $16K sold.

BlackRock first reported a position in SBIO in Q2 2020 and held it in 1 quarter. The position peaked at $16K in Q2 2020. 52 funds tracked by Wall St. Rank hold SBIO as of Q3 2020.

  • BlackRock reported no remaining ALPS Medical Breakthroughs ETF position as of Q3 2020 after selling out during the quarter.
  • BlackRock sold 371 ALPS Medical Breakthroughs ETF shares in Q3 2020, an estimated $16K.
  • BlackRock first reported a position in ALPS Medical Breakthroughs ETF in Q2 2020 and held it in 1 quarter.
  • BlackRock's ALPS Medical Breakthroughs ETF position peaked at $16K in Q2 2020.
  • 52 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2020.

Based on BlackRock's 13F filing for Q3 2020, filed 6 Nov 2020.